Measuring and Removing Genotoxic Impurities

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-15-2016, Volume 2016 eBook, Issue 2
Pages: s36-s39

Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.

Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.

Advertisement

Download

.

 

 

Related Content:

IngredientsQuality Assurance/Quality ControlQuality SystemsDevelopmentAPI Synthesis and Manufacturing, Small MoleculePharmaceutical Technology-05-15-2016
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia